Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens
Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens
批准号:
418660
负责人:
Schweizer Frank
金额:
$47.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-03-01 至 2024-03-01
中文摘要
根据联合国和世界卫生组织的说法,抗菌素耐药性是对公共卫生和经济增长的最大威胁。目前,对人类健康的最大威胁来自三种耐多药的革兰氏阴性PRIO
英文摘要
According to the United Nations and the World Health Organization antimicrobial resistance is the largest threat to public health and economic growth. Currently, the greatest threat to human health derives from three multidrug-resistant Gram-negative prio
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens
-
批准号:414617
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2019
-
负责人:Schweizer Frank
-
依托单位:
Preclinical studies on aminoglycoside-derived antibiotic adjuvants (AGDAAs)
-
批准号:388257
-
项目类别:Operating Grants
-
资助金额:$47.09万
-
财政年份:2018
-
负责人:Schweizer Frank
-
依托单位:
Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs)
-
批准号:240757
-
项目类别:Operating Grants
-
资助金额:$11.66万
-
财政年份:2011
-
负责人:Schweizer Frank
-
依托单位:
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
-
批准号:185482
-
项目类别:Operating Grants
-
资助金额:$7.54万
-
财政年份:2009
-
负责人:Schweizer Frank
-
依托单位:
Preclinical evaluation of antimicrobial ultrashort aminoglycoside- peptide conjugates
-
批准号:174446
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Schweizer Frank
-
依托单位:
海外基金